• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Dupixent recaptures top Rx, OTC pharma brand spot in April

cafead

Administrator
Staff member
  • cafead   May 08, 2024 at 11:12: PM
via This is a return to form for Dupixent, which was one of the top Rx and OTC pharma brands in 2023 but was outperformed by the likes of Vicks and Rinvoq in early 2024.

article source